MPM Oncology Impact Management GP LLC (CIK 0001721035)

Latest company ownership

Shares held
7,805,483
Last filed at
Aug 25, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
3,331,500
Last filed at
Nov 6, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
1,488,033
Last filed at
May 6, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 23, 2021 Aug 25, 2021 Cullinan Therapeutics, Inc. 10% Owner Sell 40.0 -105,894 -1.34% $3.1M
Aug 11, 2021 Aug 12, 2021 Cullinan Therapeutics, Inc. 10% Owner Sell 53.8 -2,510 -0.03% $72.9K
May 4, 2021 May 6, 2021 Werewolf Therapeutics, Inc. 10% Owner Buy 92.5 +245,000 3.81% $3.9M
Jan 12, 2021 Jan 14, 2021 Cullinan Therapeutics, Inc. 10% Owner Buy 93.8 +300,000 3.94% $6.3M
Nov 2, 2017 Nov 6, 2017 Viracta Therapeutics, Inc. 10% Owner Buy 87.5 +81,500 2.51% $226K